TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01533571

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Immediate implant placement with simultaneous bone grafting
Description: * Flapless surgery is used for surgical implant installation.~* Implant is placed in the cingulum position of adjacent teeth incisal edge.~* After placement of optimal implant the remaining gap between the implant and the surrounding bony walls should be at least 2 mm or should be need for GBR of buccal plate outside the socket.~* Two types of bone graft materials will be applied for two groups of patients: Group I - natural bovine bone grafting material + resorbable natural soft tissue membrane; Group II - processed human allograft + resorbable natural soft tissue membrane .~Crown can be fixed on abutment if there is initial stability under 35 Ncm insertion torque. If insertion torque will be less, crown should be bond to neighboring teeth using composite material.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Immediate implant placement with simultaneous bone grafting
Description: * Flapless surgery is used for surgical implant installation.~* Implant is placed in the cingulum position of adjacent teeth incisal edge.~* After placement of optimal implant the remaining gap between the implant and the surrounding bony walls should be at least 2 mm or should be need for GBR of buccal plate outside the socket.~* Two types of bone graft materials will be applied for two groups of patients: Group I - natural bovine bone grafting material + resorbable natural soft tissue membrane; Group II - processed human allograft + resorbable natural soft tissue membrane .~Crown can be fixed on abutment if there is initial stability under 35 Ncm insertion torque. If insertion torque will be less, crown should be bond to neighboring teeth using composite material.
Study: NCT02218528

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Plant-based ingredient

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Plant-based ingredient

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Plant-based ingredient

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Plant-based ingredient

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: No Plant-based ingredient

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: No Plant-based ingredient
Study: NCT03331133

Intervention type: OTHER
Intervention: No intervention

Intervention type: OTHER
Intervention: No intervention
Study: NCT04084977

Intervention type: DIAGNOSTIC_TEST
Intervention: Antibody detection
Description: detecting anti bodies against D1, D2 receptor, tubolin Lysoganglioside

Intervention type: DIAGNOSTIC_TEST
Intervention: Antibody detection
Description: detecting anti bodies against D1, D2 receptor, tubolin Lysoganglioside

Intervention type: DIAGNOSTIC_TEST
Intervention: Antibody detection
Description: detecting anti bodies against D1, D2 receptor, tubolin Lysoganglioside
Study: NCT03748017

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo-Control Supplement
Description: A once-daily oral dose of the placebo-control supplement will be consumed by adults for 14 consecutive days.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Streptococcus-Containing Probiotic Supplement
Description: A once-daily oral dose of the streptococcus-containing probiotic supplement will be consumed by adults for 14 consecutive days.
Study: NCT04169711

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARO-HIF2
Description: Multiple doses of ARO-HIF2 by intravenous infusion
Study: NCT03332641

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Citron peel extract
Description: Citron peel extract for 12 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for 12 weeks
Study: NCT03735563

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Individuals will receive randomly either ketamine or fentanyl as a premedication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl
Description: Individuals will receive randomly either ketamine or fentanyl as a premedication
Study: NCT01515189

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Study: NCT02746042

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sinupret extract coated tablets
Description: 1 coated tablet 3 times a day for 16-weeks (1-1-1)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo coated tablets
Description: 1 coated tablet 3 times a day for 16-weeks (1-1-1)
Study: NCT03733743

Intervention type: OTHER
Group type: OTHER
Intervention: Standardized living protocol
Description: Subjects stay at the research facility for 44 hours and adhere to a standard sleeping, eating and activity protocol. During this protocol, multiple measurements will be performed including skeletal muscle biopsies (m. vastus lateralis), blood draws, indirect calorimetry and MRS measurements.
Study: NCT04548271

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Anti-PD-1 targeted immunotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib
Description: A small-molecule vascular endothelial growth factors receptor (VEGFR) tyrosine kinase inhibitor
Study: NCT03676920

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Discussions of Cost App (DISCO App)
Description: The DISCO App is an app-based and patient-focused intervention designed to improve the frequency and quality of patient-oncologist treatment cost discussions. The DISCO App allows patients to provide basic demographic information (e.g., employment status, insurance status, etc), and uses that information to provide patients with an individually-tailored list of treatment cost questions they can ask their provider.
Study: NCT00581633

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: normal saline (0.9%)
Description: liter normal saline over 30 minutes x 1 dose
Study: NCT05482737

Intervention type: OTHER
Intervention: no intervention
Description: This is an observational retrospective study (meta-analysis)

Intervention type: OTHER
Intervention: no intervention
Description: This is an observational retrospective study (meta-analysis)
Study: NCT02798276

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: AGTP-treatment
Description: Patients with a myocardial necrosis candidates for revascularization of other myocardial areas, will be enrolled. The non-revascularizable area will be covered with the adipose graft and the revascularizable area will be treated with the normal procedure (by-pass).

Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Patients with a myocardial necrosis, candidates for revascularization of other myocardial areas, will be enrolled. The non-revascularizable area will be left untouched and the revascularizable area will be treated normally (by-pass).
Study: NCT04341415

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Auricular neuromodulation
Description: The pose is carried out by the principal investigator, alone, without the presence of the nursing staff in the room.~Ear disinfection and sterile neuromodulation needle placement (service protocol with Chlorhexidine) Placement of 4 semi-permanent Classic needles (SEDATELEC®) on each ear flap at the level of the concha (innervated by the vagus nerve) according to an order and a precise location (4 cardinal points conch), i.e. 8 needles per patient.~Compress soaked with Oxygenated water on the concha (to stop potential bleeding).~Placing an opaque dressing on the ear and a non-occlusive Band-Aid

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Control
Description: The pose is carried out by the principal investigator, alone, without the presence of the nursing staff in the room.~Ear disinfection and sterile manipulation without needle placement (service protocol with Chlorhexidine) No needle laying but only sterile disinfection and pressure over the 4 putative locations with the sterile plastic tip (without the needle).~Compress soaked with Oxygenated water on the concha. Placing an opaque dressing on the ear and a non-occlusive Band-Aid.
Study: NCT02391545

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duvelisib
Description: PI3K Inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duvelisib
Description: PI3K Inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: monoclonal antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: monoclonal antibody
Study: NCT02924558

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Egg protein/unsaturated fatty acid
Description: Study test foods (yogurt, muffins, waffles, and cookies) containing 8% higher protein energy (egg protein) and 8% higher fat energy (unsaturated fatty acids) than Control

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Study test foods (yogurt, muffins, waffles, and cookies) containing 16% higher carbohydrate energy than Egg protein/unsaturated fatty acid
Study: NCT02968121

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brexpiprazole, OPDC-34712
Study: NCT02968121

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brexpiprazole, OPDC-34712

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brexpiprazole, OPDC-34712

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brexpiprazole, OPDC-34712

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brexpiprazole, OPDC-34712
Study: NCT03196466

Intervention type: BIOLOGICAL
Intervention: clobazam
Description: titration

Intervention type: BIOLOGICAL
Intervention: brivaracétam
Description: titration
Study: NCT05482737

Intervention type: OTHER
Intervention: no intervention
Description: This is an observational retrospective study (meta-analysis)

Intervention type: OTHER
Intervention: no intervention
Description: This is an observational retrospective study (meta-analysis)

Intervention type: OTHER
Intervention: no intervention
Description: This is an observational retrospective study (meta-analysis)

Intervention type: OTHER
Intervention: no intervention
Description: This is an observational retrospective study (meta-analysis)

Intervention type: OTHER
Intervention: no intervention
Description: This is an observational retrospective study (meta-analysis)
Study: NCT04978545

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: calciumhydroxide, intracanal medicament
Description: In the CH group, calcium hydroxide powder (Calxyl; OCO Products, Dirnstein, Germany) was mixed with saline in a ratio 1:1 and the paste was inserted into the canal by using lentulo spirals (Malleifer-Dentsply).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: chlorhexidine, intracanal medicament
Description: , chlorhexidine gel 2% (Gluco-Chex 2% gel, Cerkamed, Stalowa Wola, Polland) was placed into the root canals of this group with an Ultradent Capillary Tip (Ultradent products).
Study: NCT03622879

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MT
Description: A customised angle-adjustable frame with a mirror board (60 × 90 cm) will be used. All subjects are instructed to perform hip flexion/abduction, knee flexion/extension and ankle dorsiflexion/plantarflexion on the intact-limb during a 15 minutes period.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: MT
Description: A customised angle-adjustable frame with a mirror board (60 × 90 cm) will be used. All subjects are instructed to perform hip flexion/abduction, knee flexion/extension and ankle dorsiflexion/plantarflexion on the intact-limb during a 15 minutes period.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENS
Description: TENS will be delivered to the common peroneal nerve of the paretic leg. The stimulation frequency will be 100Hz and with an intensity just below the motor threshold.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: TENS
Description: TENS will be delivered to the common peroneal nerve of the paretic leg. The stimulation frequency will be 100Hz and with an intensity just below the motor threshold.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lower-limb task-oriented training
Description: The lower-limb task-oriented training comprises 6 exercises, namely stepping up and down, heel lift a dorsiflexed position, partial squatting, kicking a ball with alternate legs, gait re-education and transition training. Each exercise last for 10 minutes

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Lower-limb task-oriented training
Description: The lower-limb task-oriented training comprises 6 exercises, namely stepping up and down, heel lift a dorsiflexed position, partial squatting, kicking a ball with alternate legs, gait re-education and transition training. Each exercise last for 10 minutes

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Lower-limb task-oriented training
Description: The lower-limb task-oriented training comprises 6 exercises, namely stepping up and down, heel lift a dorsiflexed position, partial squatting, kicking a ball with alternate legs, gait re-education and transition training. Each exercise last for 10 minutes

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Lower-limb task-oriented training
Description: The lower-limb task-oriented training comprises 6 exercises, namely stepping up and down, heel lift a dorsiflexed position, partial squatting, kicking a ball with alternate legs, gait re-education and transition training. Each exercise last for 10 minutes
Study: NCT03312686

Intervention type: DIAGNOSTIC_TEST
Intervention: endoflip
Description: Resolution of esophageal eosinophilia by a 2-month course of high dose PPI in patients will lead to improvement in esophageal distensibility, and thus should produce improvement in dysphagia symptoms.
Study: NCT02917577

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Avaxim Pediatric®
Description: 2 doses (0.5 mL each) 6 months apart of Avaxim Pediatric® vaccine.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Avaxim ® (adult)
Description: 2 doses (0.5 mL each) 6 months apart of Avaxim ® (adult) vaccine.
Study: NCT03780374

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Phonak Audéo L2M with Sound Processing Principle 1
Description: Compensation of a hearing loss with Sound Processing Principle 1.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Audéo L2M with Sound Processing Principle 2
Description: Compensation of a hearing loss with Sound Processing Principle 2.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Audéo L2M with Sound Processing Principle 3
Description: Compensation of a hearing loss with Sound Processing Principle 3.
Study: NCT02579356

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telmisartan

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telmisartan

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telmisartan

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telmisartan

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Study: NCT02286167

Intervention type: OTHER
Group type: OTHER
Intervention: Diet modification
Description: All patients will be participate in the intermittent, modified Atkins diet
Study: NCT03429790

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: intra-operative cell salvage
Description: intra-operative cell salvage collects the patient's blood lost during an operation, processes it and returns it to their own circulation.

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: allogeneic blood transfusion
Description: transfuse allogeneic blood to patients if blood transfusion is needed.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: allogeneic blood transfusion
Description: transfuse allogeneic blood to patients if blood transfusion is needed.
Study: NCT04023149

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: recombinant human interleukin-2 (rhIL-2)
Description: Drug: rhIL-2; Pharmaceutical form: solution; Route of administration: oral gargle.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Drug: placebo; Pharmaceutical form: solution; Route of administration: oral gargle.
Study: NCT05581615

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inulin
Description: Each intervention provided 10 g/d inulin split into two dosages of 5 g.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Inulin
Description: Each intervention provided 10 g/d inulin split into two dosages of 5 g.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inulin
Description: Each intervention provided 10 g/d inulin split into two dosages of 5 g.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inulin
Description: Each intervention provided 10 g/d inulin split into two dosages of 5 g.
Study: NCT04124016

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inulin
Description: Powder of inulin fractions dissolved into 250 ml of water

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: green tea extract
Description: Powder of green tea extract dissolved into 200 ml of water

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: grape seed
Description: Powder of grape seed extract (rich in di-hydroxylated flavan-3-ol monomers) dissolved into 200 ml of water

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: grape seed extract
Description: Powder of grape seed extract (rich in di-hydroxylated flavan-3-ol oligomers) dissolved into 200 ml of water
Study: NCT02876003

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-202
Description: G-202 administered by intravenous infusion (IV, in the vein) on Days 1, 2 and 3 of each 28-day cycle until progression or development of unacceptable toxicity
Study: NCT02760329

Intervention type: PROCEDURE
Intervention: Blood draw
Description: Biomarkers analyses

Intervention type: PROCEDURE
Intervention: Urine
Description: Biomarker analyses

Intervention type: PROCEDURE
Intervention: Lung function measurements
Description: FEV1, FVC, PEF, FEF25-75%, IC, calculated FEV1/FVC ratio and calculated FEV1 % predicted

Intervention type: PROCEDURE
Intervention: Fractional Exhaled Nitric Oxide (FENO)
Description: Measures level of exhaled nitric oxide.
Study: NCT02690077

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Family-Centered Cesarean
Description: Procedure involves lowering part of the surgical drape exposing a transparent window through which the mother can watch the birth of her baby; the baby will be placed on her chest immediately after the delivery. Cleaning and evaluation of the baby will be done by a nurse who is standing at the head of the bed.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Family-Centered Cesarean
Description: Procedure involves lowering part of the surgical drape exposing a transparent window through which the mother can watch the birth of her baby; the baby will be placed on her chest immediately after the delivery. Cleaning and evaluation of the baby will be done by a nurse who is standing at the head of the bed.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Cesarean
Description: Procedure involves keeping the surgical drape up throughout the entire surgery so that the birthing process will not be visible to the mother, and the baby will be taken to the warmer to be evaluated and cleaned after birth but is available to be laid on the mother's chest at any point upon request.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Cesarean
Description: Procedure involves keeping the surgical drape up throughout the entire surgery so that the birthing process will not be visible to the mother, and the baby will be taken to the warmer to be evaluated and cleaned after birth but is available to be laid on the mother's chest at any point upon request.
Study: NCT00579657

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control diet, supported by dietary supplement twice daily
Description: control diet, see above

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high cereal fiber diet, supported by dietary supplement twice daily
Description: high cereal fiber diet, see above

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high protein diet, supported by dietary supplement twice daily
Description: high protein diet, see above

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: diet moderately high both in cereal fiber and protein, supported by dietary supplement twice daily
Description: MIX diet, see above
Study: NCT04679597

Intervention type: DRUG
Intervention: Capecitabine
Description: comparison of two treatments

Intervention type: DRUG
Intervention: Capecitabine
Description: comparison of two treatments
Study: NCT04376255

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented Reality (AR)
Description: AR headset - a device that the participants will wear over their head and eyes and will add holographic elements to a live view of workplace training scenario
Study: NCT03816332

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Description: Given PO
Study: NCT01198067

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Given PO
Study: NCT03483597

Intervention type: OTHER
Intervention: TSQM-II
Description: Treatment Satisfaction Questionnaire for Medication (TSQM Version II) will be used in all groups
Study: NCT00930943

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxymorphone ER
Description: 40 mg qd twice

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxymorphone ER
Description: 40 mg qd twice
Study: NCT01759654

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AdimFlu-V